Nifty
Sensex
:
:
18306.65
61477.17
38.25 (0.21%)
126.91 (0.21%)

Pharmaceuticals & Drugs

Rating :
54/99

BSE: 500009 | NSE: AMBASARABH

29.90
26-Oct-2021
  • Open
  • High
  • Low
  • Previous Close
  •  29.40
  •  30.35
  •  29.40
  •  29.65
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  629
  •  36.79
  •  65.00
  •  16.60

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 229.13
  • 4.16
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 237.60
  • N/A
  • 2.70

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 30.76%
  • 2.36%
  • 62.64%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 4.24%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 5.32
  • 0.23
  • 2.22

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -20.83
  • -31.60
  • -30.53

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -20.34
  • 142.70

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 6.26
  • 18.46

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.21
  • 3.44
  • 3.66

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.65
  • 1.50
  • 9.24

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 21
Jun 20
Var%
Mar 21
Mar 20
Var%
Dec 20
Dec 19
Var%
Sep 20
Sep 19
Var%
Net Sales
42.73
26.72
59.92%
48.46
38.56
25.67%
46.05
31.71
45.22%
42.42
32.27
31.45%
Expenses
35.45
26.62
33.17%
54.33
37.19
46.09%
45.41
33.40
35.96%
39.07
32.84
18.97%
EBITDA
7.28
0.10
7,180.00%
-5.87
1.37
-
0.63
-1.69
-
3.35
-0.57
-
EBIDTM
17.04%
0.38%
-12.12%
3.55%
1.38%
-5.33%
7.89%
-1.76%
Other Income
30.73
1.55
1,882.58%
25.31
15.93
58.88%
1.58
3.35
-52.84%
2.14
2.23
-4.04%
Interest
0.59
0.82
-28.05%
0.54
0.85
-36.47%
0.81
0.55
47.27%
0.78
0.99
-21.21%
Depreciation
0.56
0.65
-13.85%
0.50
1.03
-51.46%
0.67
0.52
28.85%
0.59
0.50
18.00%
PBT
21.86
0.19
11,405.26%
18.39
15.41
19.34%
0.73
0.58
25.86%
4.12
0.17
2,323.53%
Tax
2.14
0.40
435.00%
0.58
1.10
-47.27%
1.24
-0.07
-
0.97
-0.12
-
PAT
19.72
-0.22
-
17.82
14.31
24.53%
-0.50
0.65
-
3.15
0.29
986.21%
PATM
46.16%
-0.81%
36.77%
37.11%
-1.09%
2.05%
7.42%
0.88%
EPS
3.47
0.12
2,791.67%
2.04
1.69
20.71%
0.26
0.06
333.33%
1.41
0.01
14,000.00%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
179.66
133.50
151.88
125.00
133.88
131.98
124.50
104.65
100.24
88.98
79.51
Net Sales Growth
38.99%
-12.10%
21.50%
-6.63%
1.44%
6.01%
18.97%
4.40%
12.65%
11.91%
 
Cost Of Goods Sold
106.06
79.34
89.52
70.20
76.92
72.88
72.73
58.10
54.18
51.56
50.14
Gross Profit
73.60
54.16
62.36
54.81
56.95
59.11
51.76
46.55
46.07
37.42
29.37
GP Margin
40.96%
40.57%
41.06%
43.85%
42.54%
44.79%
41.57%
44.48%
45.96%
42.05%
36.94%
Total Expenditure
174.26
135.40
145.99
136.74
144.95
144.67
128.83
113.27
110.61
101.33
99.15
Power & Fuel Cost
-
2.71
3.22
2.84
2.68
3.67
2.80
2.36
2.97
2.11
2.23
% Of Sales
-
2.03%
2.12%
2.27%
2.00%
2.78%
2.25%
2.26%
2.96%
2.37%
2.80%
Employee Cost
-
27.06
26.02
26.67
28.71
31.29
28.47
27.39
30.28
26.86
25.66
% Of Sales
-
20.27%
17.13%
21.34%
21.44%
23.71%
22.87%
26.17%
30.21%
30.19%
32.27%
Manufacturing Exp.
-
4.07
5.09
5.18
5.43
7.13
5.53
6.00
5.12
4.53
3.84
% Of Sales
-
3.05%
3.35%
4.14%
4.06%
5.40%
4.44%
5.73%
5.11%
5.09%
4.83%
General & Admin Exp.
-
11.94
10.92
24.21
12.52
13.39
10.03
9.56
8.93
7.09
5.21
% Of Sales
-
8.94%
7.19%
19.37%
9.35%
10.15%
8.06%
9.14%
8.91%
7.97%
6.55%
Selling & Distn. Exp.
-
7.03
7.92
4.86
6.53
6.42
6.08
4.66
4.11
4.12
5.18
% Of Sales
-
5.27%
5.21%
3.89%
4.88%
4.86%
4.88%
4.45%
4.10%
4.63%
6.51%
Miscellaneous Exp.
-
3.26
3.30
2.79
12.16
9.90
3.19
5.18
5.02
5.05
5.18
% Of Sales
-
2.44%
2.17%
2.23%
9.08%
7.50%
2.56%
4.95%
5.01%
5.68%
8.65%
EBITDA
5.39
-1.90
5.89
-11.74
-11.07
-12.69
-4.33
-8.62
-10.37
-12.35
-19.64
EBITDA Margin
3.00%
-1.42%
3.88%
-9.39%
-8.27%
-9.62%
-3.48%
-8.24%
-10.35%
-13.88%
-24.70%
Other Income
59.76
24.39
5.47
25.04
6.22
95.08
12.99
3.01
16.41
4.08
8.74
Interest
2.72
3.61
3.29
3.41
4.77
4.10
9.83
10.93
8.52
9.69
11.30
Depreciation
2.32
2.57
2.10
2.12
4.27
16.54
4.81
3.01
14.02
2.90
2.78
PBT
45.10
16.31
5.97
7.77
-13.90
61.74
-5.98
-19.55
-16.50
-20.86
-24.98
Tax
4.93
0.88
3.97
6.69
4.61
13.61
0.69
0.66
1.48
1.04
3.87
Tax Rate
10.93%
5.40%
66.50%
86.10%
-33.17%
22.04%
-11.54%
-3.38%
-8.97%
-10.75%
-52.58%
PAT
40.19
15.44
2.00
1.08
-18.51
48.14
-6.67
-20.21
-17.97
-10.71
-11.23
PAT before Minority Interest
40.19
15.44
2.00
1.08
-18.51
48.14
-6.67
-20.21
-17.97
-10.71
-11.23
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
22.37%
11.57%
1.32%
0.86%
-13.83%
36.48%
-5.36%
-19.31%
-17.93%
-12.04%
-14.12%
PAT Growth
167.40%
672.00%
85.19%
-
-
-
-
-
-
-
 
EPS
5.25
2.02
0.26
0.14
-2.42
6.28
-0.87
-2.64
-2.35
-1.40
-1.47

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
44.77
30.62
26.52
25.17
38.73
-9.40
-2.16
17.94
36.46
47.38
Share Capital
76.63
76.63
76.63
76.63
76.63
76.63
76.63
76.63
76.63
76.63
Total Reserves
-31.87
-46.01
-50.12
-51.46
-37.90
-86.04
-78.79
-58.69
-40.18
-29.25
Non-Current Liabilities
4.80
8.90
11.39
5.83
12.70
15.43
59.01
17.14
15.99
21.37
Secured Loans
4.54
8.76
11.12
5.11
5.72
5.76
3.20
4.09
3.25
12.62
Unsecured Loans
0.00
0.00
0.00
0.00
0.02
0.00
0.00
0.00
0.00
8.56
Long Term Provisions
3.37
3.80
4.38
5.53
6.75
9.85
55.84
12.33
12.30
0.00
Current Liabilities
133.47
171.32
155.44
124.43
152.51
162.77
154.55
175.34
170.71
171.90
Trade Payables
40.02
46.83
39.76
29.14
26.93
27.54
28.33
21.13
33.31
31.70
Other Current Liabilities
65.86
91.29
80.43
50.08
56.70
91.85
86.32
73.61
65.73
71.01
Short Term Borrowings
23.66
28.76
30.34
35.33
39.50
38.92
36.67
33.45
24.55
0.00
Short Term Provisions
3.92
4.44
4.91
9.88
29.38
4.46
3.22
47.15
47.12
69.19
Total Liabilities
183.03
210.83
193.35
155.43
203.94
168.80
211.40
210.42
223.16
240.65
Net Block
57.46
57.65
59.16
72.25
71.76
90.78
94.32
98.39
111.21
112.22
Gross Block
68.25
65.91
65.36
76.34
138.02
153.64
152.39
154.51
155.91
153.82
Accumulated Depreciation
10.79
8.26
6.20
4.09
66.26
62.86
58.07
56.11
44.69
41.60
Non Current Assets
79.06
94.58
79.79
82.18
91.54
100.43
143.97
105.56
122.72
115.57
Capital Work in Progress
0.41
24.06
13.69
3.44
8.97
0.83
0.21
0.10
0.12
1.12
Non Current Investment
18.12
9.36
5.37
4.83
8.10
0.62
0.78
1.30
2.29
2.23
Long Term Loans & Adv.
2.13
1.98
1.48
1.50
1.95
7.73
48.44
2.79
2.61
0.00
Other Non Current Assets
0.94
1.53
0.10
0.17
0.77
0.48
0.22
2.98
6.48
0.00
Current Assets
103.97
116.26
113.55
73.25
112.40
68.37
67.43
104.85
100.43
125.08
Current Investments
0.00
0.00
0.00
0.00
0.00
0.27
0.15
0.00
0.00
0.00
Inventories
16.45
14.98
14.39
13.81
14.41
17.10
15.13
13.72
12.19
10.15
Sundry Debtors
28.80
34.69
34.13
28.95
30.11
25.29
27.18
27.84
21.91
31.61
Cash & Bank
21.53
23.26
22.07
16.71
16.41
13.85
12.28
7.16
9.46
17.50
Other Current Assets
37.19
15.94
25.29
2.39
51.47
11.86
12.68
56.14
56.87
65.82
Short Term Loans & Adv.
25.94
27.39
17.66
11.38
37.98
11.41
11.18
54.83
55.48
65.82
Net Current Assets
-29.50
-55.06
-41.89
-51.18
-40.11
-94.40
-87.12
-70.48
-70.28
-46.82
Total Assets
183.03
210.84
193.34
155.43
203.94
168.80
211.40
210.41
223.15
240.65

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
-6.88
18.80
-7.39
5.40
-74.99
-8.32
11.02
-3.26
-12.80
-3.29
PBT
14.94
8.21
7.96
-13.62
61.74
-5.98
-19.55
-16.50
-9.67
-11.23
Adjustment
-13.26
1.79
-11.90
17.83
-67.13
2.50
14.47
6.76
-1.90
0.57
Changes in Working Capital
-6.07
16.64
16.46
2.77
-64.49
-0.39
17.76
8.26
8.98
10.53
Cash after chg. in Working capital
-4.40
26.65
12.53
6.98
-69.88
-3.88
12.67
-1.48
-2.60
-0.13
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-2.48
-7.84
-19.93
-1.58
-5.12
-4.44
-1.66
-1.78
-10.21
-3.15
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
16.89
-9.25
17.58
-3.31
80.06
9.80
-0.89
-0.28
10.79
8.25
Net Fixed Assets
-0.23
-0.06
1.03
56.92
20.63
0.40
0.84
2.06
0.91
9.21
Net Investments
2.59
-0.09
8.92
6.72
-26.62
-0.13
1.83
0.50
-1.55
-12.78
Others
14.53
-9.10
7.63
-66.95
86.05
9.53
-3.56
-2.84
11.43
11.82
Cash from Financing Activity
-14.22
-6.07
-2.09
-6.26
-3.44
-0.61
-8.39
2.75
0.65
-4.27
Net Cash Inflow / Outflow
-4.21
3.49
8.10
-4.17
1.62
0.87
1.74
-0.79
-1.36
0.69
Opening Cash & Equivalents
17.00
13.51
5.41
9.58
8.40
7.53
5.79
6.58
7.93
16.81
Closing Cash & Equivalent
12.79
17.00
13.51
5.41
10.03
8.40
7.53
5.79
6.58
17.50

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
5.84
4.00
3.46
3.28
5.05
-1.23
-0.28
2.34
4.76
6.18
ROA
7.84%
0.99%
0.62%
-10.30%
25.83%
-3.51%
-9.58%
-8.29%
-4.62%
-4.86%
ROE
40.95%
7.01%
4.20%
-57.92%
328.25%
0.00%
-256.13%
-66.09%
-25.55%
-21.12%
ROCE
27.36%
13.17%
16.34%
-11.94%
107.14%
10.08%
-17.91%
-12.98%
0.02%
5.56%
Fixed Asset Turnover
2.06
2.34
1.77
1.27
0.93
0.83
0.70
0.66
0.59
0.53
Receivable days
83.82
81.74
91.65
79.06
74.77
75.18
93.62
88.35
106.91
121.91
Inventory Days
41.50
34.90
40.98
37.78
42.53
46.19
49.09
46.00
44.61
44.01
Payable days
127.64
117.80
109.36
81.80
71.83
85.02
86.62
87.50
128.12
130.71
Cash Conversion Cycle
-2.32
-1.16
23.27
35.04
45.47
36.35
56.09
46.86
23.40
35.22
Total Debt/Equity
0.67
1.31
1.63
1.67
1.22
-4.94
-19.21
2.17
0.81
0.45
Interest Cover
5.52
2.81
3.28
-1.91
16.06
0.39
-0.79
-0.94
0.00
0.35

News Update:


  • Ambalal Sarabhai’s JV receives CDSCO license to manufacture SARAGENE Dengue Test Kit
    17th Sep 2021, 10:38 AM

    The tests are now available for sale

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.